Est. 2001·3,000+ placements · six offices · four regions
Capital Raisingcurated sourcedetected 2026-08-04 · confidence 95%

Last updated

Factory: Capital Raising

Factory is raising funding from Blackstone in a Series D round likely valuing the AI coding automation firm at over $3.5bn, following a $1.5bn Series C in April and a $50m seed in September 2025.

Source: City AM

What happened
Factory is raising funding from Blackstone in a Series D round likely valuing the AI coding automation firm at over $3.5bn, following a $1.5bn Series C in April and a $50m seed in September 2025.
Who
Factory · USA
When
2026-08-04
Source
City AM
So what
Factory's valuation has moved from $300m to more than $3.5bn across three rounds in under a year, a compression of the normal Series A-to-D timeline that reflects something structural, not merely sentiment.

The leadership read

Factory's valuation has moved from $300m to more than $3.5bn across three rounds in under a year, a compression of the normal Series A-to-D timeline that reflects something structural, not merely sentiment. Each round has added a strategic anchor: Nvidia and JP Morgan at seed, Sequoia and Khosla at Series C, Blackstone now. That stacking of financial and corporate-strategic capital is a deliberate architecture, not opportunistic check-writing. It commits the company to enterprise delivery at scale, Morgan Stanley, EY, and Nvidia are live customers, which means the operational surface area is already large relative to the headcount a three-year-old firm typically carries. The gap between revenue velocity and organisational depth is where the real exposure sits. The related signals from the last 90 days are a mixed set; only one, Sarvam's Nvidia-led $74m Series B extension, sits squarely in AI enterprise software. The broader capital-raising activity this week spans diagnostics, real estate, and energy infrastructure, which tells you less about AI coding specifically than about sustained cross-sector capital deployment. The more relevant pattern is the one inside the AI agent and automation corridor: multiple late-stage AI firms reaching enterprise-deployment scale with strategic investor syndicates behind them. Companies reaching this stage of capital concentration in AI enterprise automation face consistent demand for commercial leadership capable of managing strategic-investor relationships alongside direct enterprise sales, alongside engineering leadership experienced in regulated-industry deployment, financial services and professional services clients carry compliance obligations that reshape product priorities. The market is moving toward operators who can hold delivery accountability at enterprise scale without the organizational infrastructure larger incumbents carry as a matter of course.

Market context: MitchelLake's Talent Market Index sits at 122.7 (Hot), up 17.8 on the prior month; Americas hiring signal is running rising (+34.4pts).

Factory: 1 signal in the last 90 days; 4 tracked across 110 days.

MitchelLake in this thematic

Also at Factory →

More signals across Americas

Capital Raising · Americas

Antheia →

Antheia, an advanced biosynthesis pharmaceutical manufacturer, secured an $80 million conditional funding commitment from the Department of War's Office of Strategic Capital to support domestic onshoring of critical medicine supply chains.

Capital Raising · Americas

Klook Technology →

Hong Kong-based travel booking platform Klook Technology has filed to withdraw its US IPO, which it had filed for in November 2025.

Capital Raising · Americas

Strive →

Strive priced an upsized $630M IPO of SATS preferred stock.

Capital Raising · Americas

Swamp Club →

San Francisco-based AI agent platform Swamp Club raised a $7M seed round led by Amplify Partners, with Encoded Ventures and angels participating. Funds will scale its behavior-centric AI agent platform for enterprise production use.

Capital Raising · Americas

EMode Photonix →

Boulder, Colorado photonics simulation software startup EMode Photonix raised a $1M pre-seed round led by Ground State Ventures, with Harlow Capital Management participating.

Capital Raising · Americas

Frazier Life Sciences Acquisition Corp →

Frazier Life Sciences is taking a biotech-focused SPAC public on Nasdaq, a blank-check vehicle raising capital to acquire a life sciences company.

Where this lands in our work

Weekly briefing

Track companies like Factory — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

Nearby in the record